Drug Database
DO

doxycycline (Perio Product / Atridox / doxycycline, Atrix)

✓ Approved

Pharmascience, Inc. · Small Molecule · Small Molecule

What is doxycycline?

doxycycline is a small molecule developed by Pharmascience, Inc.. It is approved for therapeutic indications via oral (po) or topical.

Drug Profile

Brand NamesPerio Product, Atridox, doxycycline, Atrix
CompanyPharmascience, Inc.
Drug ClassSmall Molecule
RouteOral (PO), Topical
StatusApproved

Therapeutic Indications

doxycycline is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Infections and infestationsPeriodontitis✓ Approved

Related Research Articles

PubMedInternational journal of STD & AIDS2026-09-19

Methenamine, minocycline, metronidazole and pristinamycin (M3P) for multi-drug-resistant Mycoplasma genitalium urethritis: A case series.

Vanbaelen Thibaut T, De Baetselier Irith I, Manoharan-Basil Sheeba Santhini SS, Van Den Bossche Dorien D et al.

ObjectivesWorldwide, Mycoplasma genitalium infections are becoming more resistant to both macrolides and fluoroquinolones - termed multi-drug-resistant (MDR) infections. Combination therapy has shown promise in treating other MDR pathogens. We have previously reported the first five cases of MDR M. genitalium urethritis successfully treated with a novel combination therapy regimen consisting of minocycline, metronidazole, methenamine and pristinamycin ('M3P').MethodsWe describe a second case series of four individuals treated with M3P as salvage therapy for M. genitalium urethritis. Clinical data, laboratory findings, resistance profiles, and treatment outcomes were reviewed.ResultsAll four individuals had persistent M. genitalium urethritis and evidence of macrolide and fluoroquinolone resistance. Prior treatments included multiple courses of doxycycline, minocycline, azithromycin, fluoroquinolones, pristinamycin and other salvage regimens. Treatment with M3P for 14 days was associated with complete resolution of symptoms and negative post-treatment M. genitalium nucleic acid amplification tests in all four cases. No adverse effects were reported.ConclusionsM3P is a useful salvage therapy for MDR M. genitalium infections that do not respond to other regimens.

PubMedFood chemistry2026-09-19

Fluorometric and smartphone-based dual-mode sensor for tetracyclines by bimetallic Fe/Eu-MOFs nanocomposite in foods.

Liao Yuan Y, Shi Shuyue S, Li Xiaomin X, Gao Libo L et al.

The overuse of antibiotics has caused significant accumulation of tetracyclines (TCs) residues in the food chain, posing serious health risks. A europium- and iron-co-doped metal-organic framework (Fe/Eu-MOFs) was synthesized using a one-pot hydrothermal strategy. The Fe/Eu-MOFs demonstrate intense red fluorescence emission at 615 nm, which undergoes quenching upon the introduction of TCs. This phenomenon facilitates the selective detection of tetracycline (TC), oxytetracycline (OTC), and doxycycline (DOX), the limit of detection (LOD) values was determined to be 0.052, 0.047, and 0.062 μg/mL, respectively. The sensor exhibits exceptional selectivity and reproducibility in real matrices (milk, honey, Yellow River water), achieving 93.9%-109.5% recovery rates. Integration with smartphone-based RGB analysis allows visual online detection, enhancing field applicability. Mechanistic investigations indicate that fluorescence quenching arises from the synergistic interplay between IFE and PET. This work provides a simple, cost-effective synthesis strategy for Fe/Eu-MOFs and establishes an ultrasensitive sensing platform for TCs in complex systems.

PubMedCureus2026-09-19

Acute Febrile Multisystem Illness With Vasculitic Features in a Young Adult: A Diagnostic Challenge Between Infectious and Autoimmune Etiologies.

Ho Tan T, Kansal Shreya S, Sieverts Amanda A, Lee Michelle M et al.

Acute febrile illness with rash and multisystem involvement in a young adult has a broad differential diagnosis spanning infectious and autoimmune etiologies. We report the case of a 21-year-old male who presented with fever, a mixed-morphology rash (petechiae and palpable purpura with centripetal spread), peripheral neuropathy, polyarthritis, and transaminitis following recent travel to Tennessee and Missouri. A prodromal cough two weeks prior to rash onset added diagnostic complexity. Initial serologic testing during hospitalization was negative for Rocky Mountain spotted fever (RMSF) and dengue, and confirmatory convalescent serologies remained unavailable at discharge. Despite early corticosteroid administration for suspected small-vessel vasculitis, no clinical improvement was observed. Empiric doxycycline was initiated, given the epidemiologic risk for tick-borne illness. This case highlights the critical importance of maintaining a broad differential, avoiding premature diagnostic closure, and prioritizing empiric antimicrobial therapy over early immunosuppression in diagnostically ambiguous, febrile multisystem illness.

PubMedInfection and drug resistance2026-09-19

Analysis of Antimicrobial Resistance and Infection Characteristics of Myroides odoratimimus Harboring the bla MOC-1 Metallo-β-Lactamase Gene.

Ding Rong R, Xia Guiping G, Tong Huacheng H

To investigate the drug resistance genotype and phenotypic characteristics of a clinical isolate of Myroides odoratimimus producing metallo-β-lactamase, so as to provide reference for the diagnosis and treatment of similar severe infections in critical care settings. A Gram-negative bacillus isolated from blood cultures of an elderly patient with severe bloodstream infection was identified using the Vitek 2 Compact system combined with 16S rRNA gene sequencing. Antimicrobial susceptibility testing was performed using the broth microdilution method to determine minimum inhibitory concentrations (MICs). Metallo-β-lactamase phenotype was identified by the modified carbapenem inactivation method (mCIM) combined with the EDTA-modified carbapenem inactivation method (eCIM). The isolate was identified as Myroides odoratimimus. Both mCIM and eCIM tests were positive, confirming the production of metallo-β-lactamase. Whole-genome sequencing and database comparison revealed the presence of the blaMOC-1 gene in this strain, and PCR amplification followed by sequencing of electrophoretic bands yielded a 629-bp blaMOC-1 sequence. Antimicrobial susceptibility testing showed that the isolate exhibited broad-spectrum resistance and was only susceptible to minocycline, doxycycline, levofloxacin, and cefepime. The patient presented with severe septic shock, showed no response to empirical therapy, developed multiple organ injury, and exhibited abnormally elevated biomarkers of inflammation, metabolism, and cardiovascular function. The findings of this study suggest that the blaMOC-1 gene is carried by this strain and is associated with its broad-spectrum antimicrobial resistance characteristics.

PubMedAnnals of emergency medicine2026-09-18

Doxycycline With a β-Lactam Should Be Considered for Empiric Treatment of Community-Acquired Pneumonia in Critically Ill Adults.

Rech Megan A MA, Gottlieb Michael M

PubMedMicrobiology spectrum2026-09-18

Gain and loss of acquired doxycycline resistance in Lactiplantibacillus plantarum: an adaptive laboratory evolution study.

Pierce Bryce B, Harrison Olivia Love OL, Floyd Brooks B, Moriarty Agnes A et al.

Probiotics interact in a mutualistic way with humans. Exposure of probiotics to sublethal concentrations of commonly prescribed antibiotics can cause resistance to arise. Over 1,000 generations, we performed an adaptive laboratory evolution experiment to determine if the fitness of the probiotic Lactiplantibacillus plantarum is altered by exposure to doxycycline (DOX) at one-tenth of the minimal inhibitory concentration. Compared to the original culture, L. plantarum exposed to sublethal DOX acquired modest resistance (~4-fold) over time. When the selection pressure was removed, resistance was lost rapidly in ~50 generations. This suggests that resistance, once acquired, is not fixed. The mechanism by which resistance is acquired and subsequently lost was investigated by whole genome sequencing (WGS). Analysis of the single-nucleotide variants (SNVs) identified in the WGS of the generation 1,000 DOX-treated cultures reveals 16 distinct variants across 15 genes. Two of these variants are in the rpsJ gene, which encodes ribosomal protein S10, a component of the 30S ribosomal subunit, and result in non-synonymous mutations (H56Y and S94N). This gene has been previously reported to harbor mutations associated with tetracycline-class resistance, including DOX and tigecycline. WGS of archived cells from generations 350 and 750 reveals that one of these rpsJ variants (H56Y) arises early in the experiment. Additional rpsJ variants at position 57 (K57M and K57I) could be identified within intermediate generations. Most rpsJ SNVs identified from the WGS could be verified by colony PCR and Sanger sequencing. Importantly, no rpsJ variants are observed in the original culture sequences or in same-generation controls.IMPORTANCEProbiotics are beneficial bacteria often found in fermented foods and beverages. When consumed, they can colonize the gut and provide several advantages. Antibiotics, even at levels too low to kill bacteria, can exert pressure that leads to antibiotic resistance. Though well studied in harmful bacteria, the effects this may have on probiotics are less well understood. Using experimental evolution, we grew a popular probiotic, Lactiplantibacillus plantarum, in the presence of a low concentration of doxycycline, one of the most highly prescribed antibiotics in the US. Over the course of 5 months, roughly a thousand generations, the probiotic became ~4-fold more resistant; once we removed the antibiotic and continued the experiment, this resistance disappeared rapidly. DNA sequencing identified variants in the rpsJ gene, which encodes a protein important for translation. As doxycycline interferes with this process, the rpsJ variants may underlie the emergence of the modest resistance we observe.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about doxycycline